Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models.
about
Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studiesFLT-PET for early response evaluation of colorectal cancer patients with liver metastases: a prospective study[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941.Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment.
P2860
Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Early assessment of tumor resp ...... e in preclinical tumor models.
@en
type
label
Early assessment of tumor resp ...... e in preclinical tumor models.
@en
prefLabel
Early assessment of tumor resp ...... e in preclinical tumor models.
@en
P2093
P2860
P1476
Early assessment of tumor resp ...... ne in preclinical tumor models
@en
P2093
Dae Hyuk Moon
Hwan Mook Kim
Hye Young Kang
Jin Hwa Chung
Jin-Sook Ryu
Jong Soon Kang
Myung-Hwa Kim
Seog Young Kim
Seung Jun Oh
Song-Kyu Park
P2860
P2888
P304
P356
10.1007/S00259-011-1802-4
P577
2011-04-12T00:00:00Z